Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine-Reference-Cited by-同舟云学术

Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine

Published:2018-07-18 Issue:10 Volume:103 Page:3698-3705
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Jaber Tania¹,Waguespack Steven G¹,Cabanillas Maria E¹,Elbanan Mohamed²,Vu Thinh³,Dadu Ramona¹,Sherman Steven I¹,Amit Moran⁴,Santos Elmer B⁵,Zafereo Mark⁴,Busaidy Naifa L¹

Affiliation:

1. Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas

2. Department of Quantitative Imaging Analysis Core, The University of Texas MD Anderson Cancer Center, Houston, Texas

3. Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas

4. Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

5. Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

Funder

National Cancer Institute

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/103/10/3698/25902571/jc.2018-00612.pdf

Reference28 articles.

1. Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease;Busaidy;J Thyroid Res,2012

2. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

3. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy;Durante;J Clin Endocrinol Metab,2006

4. National Comprehensive Cancer Network. Thyroid Cancer (version 2.2017). www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf. Accessed 28 August 2017.

5. Optimizing therapy for radioactive iodine-refractory differentiated thyroid cancer: current state of the art and future directions;Dadu;Minerva Endocrinol,2012

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of the BRAFV600E Mutation in Circulating Free Nucleic Acids as a Biomarker of Thyroid Cancer: A Review;Journal of Clinical Medicine;2024-09-12

2. An update on redifferentiation strategies for radioactive iodine-refractory differentiated thyroid carcinoma;Endocrine;2024-09-04

3. Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer;Expert Opinion on Pharmacotherapy;2024-08-12

4. Comparative Uptake Patterns of Radioactive Iodine and [18F]-Fluorodeoxyglucose (FDG) in Metastatic Differentiated Thyroid Cancers;Journal of Clinical Medicine;2024-07-06

5. Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report;Medicina;2024-06-25